Testing a New Appetite-Control Medicine in Healthy Adults
This study tests a new drug called DNF-10 that may help regulate how your body signals hunger and fullness. Researchers want to see how it affects appetite in healthy people with normal to slightly elevated weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult between 20 and 50 years old
- Have a normal to moderately elevated weight (BMI between 18.5–29.9 kg/m²)
- Not have an eating disorder or recent major weight changes (no 10%+ gain or loss in the last 3 months)
- Not be taking weight-loss medications, GLP-1 drugs (like Ozempic), or appetite-affecting supplements
- Not have diabetes, thyroid disease, kidney disease, depression, or anxiety that affects eating
- Agree not to change your diet or exercise routine during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests an experimental drug (NNC0487-0111) to see how it changes food intake, appetite, and the way your body processes food after meals. It is for adults with obesity who do not have diabetes.
This early-stage trial tests how safe and tolerable CMS-D008, an experimental weight-management medicine, is in healthy adults who are overweight or obese. Researchers will gradually increase the dose to find the right amount and monitor how your body responds.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This trial tests a new medication called DA-1726 for people with obesity but no other major health problems. It aims to see if the drug is safe and how it works in the body. You may qualify if your body mass index (BMI) is between 30 and 45 and your weight has been stable for 3 months.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
Hear when a new Healthy Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.